ALMIB — Amoeba SA Share Price
- €54.32m
- €65.92m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | n/a | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -1252.9% | ||
Return on Equity | n/a | ||
Operating Margin | n/a |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | €m | n/a | n/a | n/a | n/a | n/a | 0.55 | 4.15 | -100% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Amoeba SA is a France-based company that develops, manufactures and markets biological products. The Company specializes in disruptive biological solutions for the treatment of Legionella, amoeba and biofilm in water. The Company's offering includes products and services, such as: Cleantech biological solution, a patented technological disruptive product with no impact on the environment; amoebic analyses of waters of wet cooling towers (TAR), hot sanitary waters, industrial waters and waters of swimming pools; as well as Legionella tests of industrial waste water, among others. The Company is engaged in various technical, commercial, industrial and investment partnerships.
Directors
- Fabrice Plasson CHM (49)
- Valerie Filiatre DCE (60)
- Bernard Ambolet IND (68)
- Philippe Dujardin IND
- Ghislaine Pinochet IND (62)
- Claudine Vermot-Desroches IND (56)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 9th, 2010
- Public Since
- July 10th, 2015
- No. of Employees
- 18
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
Euronext - Paris
- Shares in Issue
- 49,659,963

- Address
- 38 avenue des Freres Montgolfier, CHASSIEU, 69680
- Web
- https://amoeba-nature.com/en/
- Phone
- +33 426691600
- Auditors
- MAZARS
Upcoming Events for ALMIB
Half Year 2025 Amoeba SA Earnings Release
Similar to ALMIB
Altheora SA
Euronext - Paris
Arkema SA
Euronext - Paris
Baikowski SA
Euronext - Paris
Carbios SA
Euronext - Paris
FAQ
As of Today at 19:13 UTC, shares in Amoeba SA are trading at €1.09. This share price information is delayed by 15 minutes.
Shares in Amoeba SA last closed at €1.09 and the price had moved by +153.78% over the past 365 days. In terms of relative price strength the Amoeba SA share price has outperformed the FTSE Global All Cap Index by +147.43% over the past year.
The overall consensus recommendation for Amoeba SA is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreAmoeba SA does not currently pay a dividend.
Amoeba SA does not currently pay a dividend.
Amoeba SA does not currently pay a dividend.
To buy shares in Amoeba SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €1.09, shares in Amoeba SA had a market capitalisation of €54.32m.
Here are the trading details for Amoeba SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: ALMIB
Based on an overall assessment of its quality, value and momentum Amoeba SA is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Amoeba SA is €1.60. That is 46.28% above the last closing price of €1.09.
Analysts covering Amoeba SA currently have a consensus Earnings Per Share (EPS) forecast of -€0.15 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Amoeba SA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +73.67%.
As of the last closing price of €1.09, shares in Amoeba SA were trading +48.85% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Amoeba SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €1.09.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Amoeba SA's management team is headed by:
- Fabrice Plasson - CHM
- Valerie Filiatre - DCE
- Bernard Ambolet - IND
- Philippe Dujardin - IND
- Ghislaine Pinochet - IND
- Claudine Vermot-Desroches - IND